{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:48:07Z","timestamp":1791910087943,"version":"4.3.4"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-026-01074-9","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:07:39Z","timestamp":1782324459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beyond estrobolome 1.0: unraveling endocrine-microbiome axis as a driver and therapeutic target in hormone-driven cancers"],"prefix":"10.1038","volume":"12","author":[{"given":"Exian","family":"Mou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"1074_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/metabo14070396","volume":"14","author":"BA Bauer","year":"2024","unstructured":"Bauer, B. A. et al. A multiomics, molecular atlas of breast cancer survivors. Metabolites 14, 7 (2024).","journal-title":"Metabolites"},{"key":"1074_CR2","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/JME-15-0310","volume":"57","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Aromatase expression and regulation in breast and endometrial cancer. J. Mol. Endocrinol. 57, R19\u2013R33 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"1074_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1124\/mol.113.087700","volume":"84","author":"CR Nishida","year":"2013","unstructured":"Nishida, C. R., Everett, S. & Ortiz de Montellano, P. R. Specificity determinants of CYP1B1 estradiol hydroxylation. Mol. Pharm. 84, 451\u2013458 (2013).","journal-title":"Mol. Pharm."},{"key":"1074_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","volume":"90","author":"I Paterni","year":"2014","unstructured":"Paterni, I. et al. Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): subtype-selective ligands and clinical potential. Steroids 90, 13\u201329 (2014).","journal-title":"Steroids"},{"key":"1074_CR5","first-page":"2022","volume":"13","author":"K Yu","year":"2022","unstructured":"Yu, K. et al. Estrogen receptor function: impact on the human endometrium. Front. Endocrinol. 13, 2022 (2022).","journal-title":"Front. Endocrinol."},{"key":"1074_CR6","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1074\/jbc.RA119.010950","volume":"294","author":"SM Ervin","year":"2019","unstructured":"Ervin, S. M. et al. Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J. Biol. Chem. 294, 18586\u201318599 (2019).","journal-title":"J. Biol. Chem."},{"key":"1074_CR7","doi-asserted-by":"publisher","first-page":"2236749","DOI":"10.1080\/19490976.2023.2236749","volume":"15","author":"S Hu","year":"2023","unstructured":"Hu, S. et al. Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes 15, 2236749 (2023).","journal-title":"Gut Microbes"},{"key":"1074_CR8","doi-asserted-by":"crossref","unstructured":"Ervin, S. et al. Gut microbiome\u2013derived \u03b2-glucuronidases are components of the estrobolome that reactivate estrogens. J. Biol. Chem. 294, p. jbc.RA119.010950 (2019).","DOI":"10.1074\/jbc.RA119.010950"},{"key":"1074_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.chom.2024.04.018","volume":"32","author":"JB Simpson","year":"2024","unstructured":"Simpson, J. B. et al. Gut microbial \u03b2-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Cell Host Microbe 32, 925\u2013944.e10 (2024).","journal-title":"Cell Host Microbe"},{"key":"1074_CR10","doi-asserted-by":"publisher","first-page":"631552","DOI":"10.3389\/fcell.2021.631552","volume":"9","author":"Y Sui","year":"2021","unstructured":"Sui, Y., Wu, J. & Chen, J. The role of gut microbial \u03b2-glucuronidase in estrogen reactivation and breast cancer. Front Cell Dev. Biol. 9, 631552 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"1074_CR11","first-page":"2","volume":"260","author":"MTF Lamaudi\u00e8re","year":"2024","unstructured":"Lamaudi\u00e8re, M. T. F. et al. Human gut microbiota and endocrinology: paradigm shift from genome to its regulation. J. Endocrinol. 260, 2 (2024).","journal-title":"J. Endocrinol."},{"key":"1074_CR12","doi-asserted-by":"publisher","first-page":"e1003726","DOI":"10.1371\/journal.ppat.1003726","volume":"9","author":"M Lyte","year":"2013","unstructured":"Lyte, M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLOS Pathog. 9, e1003726 (2013).","journal-title":"PLOS Pathog."},{"key":"1074_CR13","doi-asserted-by":"publisher","first-page":"116218","DOI":"10.1016\/j.biopha.2024.116218","volume":"172","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. The role of microbial metabolites in endocrine tumorigenesis: From the mechanistic insights to potential therapeutic biomarkers. Biomed. Pharmacother. 172, 116218 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"1074_CR14","doi-asserted-by":"publisher","first-page":"1337373","DOI":"10.3389\/fmolb.2023.1337373","volume":"10","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning. Front Mol. Biosci. 10, 1337373 (2023).","journal-title":"Front Mol. Biosci."},{"key":"1074_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00657-2","volume":"11","author":"S Wu","year":"2025","unstructured":"Wu, S. et al. Molecules-mediated bidirectional interactions between microbes and human cells. npj Biofilms Microbiomes 11, 38 (2025).","journal-title":"npj Biofilms Microbiomes"},{"key":"1074_CR16","doi-asserted-by":"publisher","first-page":"10420","DOI":"10.1073\/pnas.0604343103","volume":"103","author":"MB Clarke","year":"2006","unstructured":"Clarke, M. B. et al. The QseC sensor kinase: a bacterial adrenergic receptor. Proc. Natl. Acad. Sci. USA 103, 10420\u201310425 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1074_CR17","doi-asserted-by":"publisher","first-page":"e1000553","DOI":"10.1371\/journal.ppat.1000553","volume":"5","author":"DT Hughes","year":"2009","unstructured":"Hughes, D. T. et al. The QseC adrenergic signaling cascade in enterohemorrhagic E. coli (EHEC). PLOS Pathog. 5, e1000553 (2009).","journal-title":"PLOS Pathog."},{"key":"1074_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jff.2012.04.013","volume":"4","author":"S Elghali","year":"2012","unstructured":"Elghali, S. et al. Bioconversion of daidzein to equol by Bifidobacterium breve 15700 and Bifidobacterium longum BB536. J. Funct. Foods 4, 736\u2013745 (2012).","journal-title":"J. Funct. Foods"},{"key":"1074_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst, G. et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364\u2013371 (2012).","journal-title":"Diabetes"},{"key":"1074_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ijo.2014.153","volume":"39","author":"A Psichas","year":"2015","unstructured":"Psichas, A. et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obes. 39, 424\u2013429 (2015).","journal-title":"Int. J. Obes."},{"key":"1074_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18259-0","volume":"8","author":"P Larraufie","year":"2018","unstructured":"Larraufie, P. et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Sci. Rep. 8, 74 (2018).","journal-title":"Sci. Rep."},{"key":"1074_CR22","doi-asserted-by":"publisher","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","volume":"13","author":"G Tong","year":"2022","unstructured":"Tong, G. et al. Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway. Front. Pharmacol. 13, 901559 (2022).","journal-title":"Front. Pharmacol."},{"key":"1074_CR23","doi-asserted-by":"publisher","first-page":"2297860","DOI":"10.1080\/19490976.2023.2297860","volume":"16","author":"A Chetty","year":"2024","unstructured":"Chetty, A. & Blekhman, R. Multi-omic approaches for host-microbiome data integration. Gut Microbes 16, 2297860 (2024).","journal-title":"Gut Microbes"},{"key":"1074_CR24","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fmicb.2024.1509117","volume":"15","author":"D Duan","year":"2025","unstructured":"Duan, D. et al. Advances in multi-omics integrated analysis methods based on the gut microbiome and their applications. Front. Microbiol. 15, 2024 (2025).","journal-title":"Front. Microbiol."},{"key":"1074_CR25","doi-asserted-by":"publisher","first-page":"167120","DOI":"10.1016\/j.bbadis.2024.167120","volume":"1870","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty, S. et al. Multi-OMICS approaches in cancer biology: new era in cancer therapy. Biochimica et. Biophysica Acta (BBA) - Mol. Basis Dis. 1870, 167120 (2024).","journal-title":"Biochimica et. Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"1074_CR26","doi-asserted-by":"publisher","first-page":"727286","DOI":"10.3389\/fcell.2021.727286","volume":"9","author":"P Chen","year":"2021","unstructured":"Chen, P. et al. Interaction between functionally activate endometrial microbiota and host gene regulation in endometrial cancer. Front Cell Dev. Biol. 9, 727286 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"1074_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00647-1","volume":"8","author":"TT Jayakrishnan","year":"2024","unstructured":"Jayakrishnan, T. T. et al. Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer. npj Precis. Oncol. 8, 146 (2024).","journal-title":"npj Precis. Oncol."},{"key":"1074_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"1074_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46888-3","volume":"15","author":"E Muller","year":"2024","unstructured":"Muller, E., Shiryan, I. & Borenstein, E. Multi-omic integration of microbiome data for identifying disease-associated modules. Nat. Commun. 15, 2621 (2024).","journal-title":"Nat. Commun."},{"key":"1074_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.str.2017.05.003","volume":"25","author":"RM Pollet","year":"2017","unstructured":"Pollet, R. M. et al. An atlas of \u03b2-glucuronidases in the human intestinal microbiome. Structure 25, 967\u2013977.e5 (2017).","journal-title":"Structure"},{"key":"1074_CR31","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.chembiol.2015.08.005","volume":"22","author":"BD Wallace","year":"2015","unstructured":"Wallace, B. D. et al. Structure and inhibition of microbiome \u03b2-glucuronidases essential to the alleviation of cancer drug toxicity. Chem. Biol. 22, 1238\u20131249 (2015).","journal-title":"Chem. Biol."},{"key":"1074_CR32","doi-asserted-by":"publisher","first-page":"18559","DOI":"10.1074\/jbc.RA118.005414","volume":"293","author":"SJ Pellock","year":"2018","unstructured":"Pellock, S. J. et al. Three structurally and functionally distinct \u03b2-glucuronidases from the human gut microbe Bacteroides uniformis. J. Biol. Chem. 293, 18559\u201318573 (2018).","journal-title":"J. Biol. Chem."},{"key":"1074_CR33","doi-asserted-by":"publisher","first-page":"E152","DOI":"10.1073\/pnas.1716241115","volume":"115","author":"MS Little","year":"2018","unstructured":"Little, M. S. et al. Structural basis for the regulation of \u03b2-glucuronidase expression by human gut Enterobacteriaceae. Proc. Natl. Acad. Sci. 115, E152\u2013E161 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1074_CR34","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3390\/ijms25052983","volume":"25","author":"L Langford","year":"2024","unstructured":"Langford, L. & Shah, D. D. Bioinformatic Analysis of Sulfotransferases from an Unexplored Gut Microbe, Sutterella wadsworthensis 3_1_45B: Possible Roles towards Detoxification via Sulfonation by Members of the Human Gut Microbiome. Int. J. Mol. Sci. 25, 2983 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1074_CR35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-022-01039-x","volume":"18","author":"AS Luis","year":"2022","unstructured":"Luis, A. S. et al. Sulfated glycan recognition by carbohydrate sulfatases of the human gut microbiota. Nat. Chem. Biol. 18, 841\u2013849 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"1074_CR36","doi-asserted-by":"crossref","unstructured":"Li, V. W. et al. Mass spectrometric profiling of estrogen and estrogen metabolites in human stool and plasma partially elucidates the role of the gut microbiome in estrogen recycling. bioRxiv. 2024.08. 07.606543 (2024).","DOI":"10.1101\/2024.08.07.606543"},{"key":"1074_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-023-02119-w","volume":"22","author":"P Hao","year":"2023","unstructured":"Hao, P. et al. Characterization of 17\u03b2-estradiol-degrading enzyme from Microbacterium sp. MZT7 and its function on E2 biodegradation in wastewater. Microb. Cell Factories 22, 116 (2023).","journal-title":"Microb. Cell Factories"},{"key":"1074_CR38","doi-asserted-by":"publisher","first-page":"130371","DOI":"10.1016\/j.jhazmat.2022.130371","volume":"444","author":"W Xiong","year":"2023","unstructured":"Xiong, W. et al. Identification of a 17\u03b2-estradiol-degrading Microbacterium hominis SJTG1 with high adaptability and characterization of the genes for estrogen degradation. J. Hazard. Mater. 444, 130371 (2023).","journal-title":"J. Hazard. Mater."},{"key":"1074_CR39","doi-asserted-by":"publisher","first-page":"G816","DOI":"10.1152\/ajpgi.00026.2020","volume":"318","author":"J Walsh","year":"2020","unstructured":"Walsh, J. et al. Impact of host and environmental factors on \u03b2-glucuronidase enzymatic activity: implications for gastrointestinal serotonin. Am. J. Physiol.-Gastrointest. Liver Physiol. 318, G816\u2013G826 (2020).","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"1074_CR40","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/nu11092231","volume":"11","author":"B Mayo","year":"2019","unstructured":"Mayo, B., V\u00e1zquez, L. & Fl\u00f3rez, A. B. Equol: a bacterial metabolite from the daidzein isoflavone and its presumed beneficial health effects. Nutrients 11, 2231 (2019).","journal-title":"Nutrients"},{"key":"1074_CR41","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/nu16071079","volume":"16","author":"LM Leonard","year":"2024","unstructured":"Leonard, L. M. et al. A gnotobiotic mouse model with divergent equol-producing phenotypes: potential for determining microbial-driven health impacts of soy isoflavone daidzein. Nutrients 16, 1079 (2024).","journal-title":"Nutrients"},{"key":"1074_CR42","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/ajcn\/81.5.1072","volume":"81","author":"KD Setchell","year":"2005","unstructured":"Setchell, K. D. et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr. 81, 1072\u20131079 (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"1074_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/molecules28010343","volume":"28","author":"S Baldi","year":"2023","unstructured":"Baldi, S. et al. Interplay between lignans and gut microbiota: nutritional, functional and methodological aspects. Molecules 28, 343 (2023).","journal-title":"Molecules"},{"key":"1074_CR44","doi-asserted-by":"crossref","unstructured":"Filippone, A. et al. Endocrine disruptors in food, estrobolome and breast cancer. J. Clin. Med. 12, 3158 (2023).","DOI":"10.3390\/jcm12093158"},{"key":"1074_CR45","doi-asserted-by":"publisher","first-page":"141707","DOI":"10.1016\/j.foodchem.2024.141707","volume":"464","author":"S Langa","year":"2025","unstructured":"Langa, S. et al. Production of equol, dehydroequol, 5-hydroxy-equol and 5-hydroxy-dehydroequol in soy beverages by the action of dihydrodaidzein reductase in Limosilactobacillus fermentum strains. Food Chem. 464, 141707 (2025).","journal-title":"Food Chem."},{"key":"1074_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-024-00625-9","volume":"16","author":"J Lv","year":"2024","unstructured":"Lv, J. et al. Equol: a metabolite of gut microbiota with potential antitumor effects. Gut Pathog. 16, 35 (2024).","journal-title":"Gut Pathog."},{"key":"1074_CR47","doi-asserted-by":"crossref","unstructured":"Iino, C. et al. Daidzein intake is associated with equol producing status through an increase in the intestinal bacteria responsible for equol production. Nutrients. 11, (2019).","DOI":"10.3390\/nu11020433"},{"key":"1074_CR48","doi-asserted-by":"publisher","first-page":"e034126","DOI":"10.1161\/JAHA.123.034126","volume":"13","author":"S Liang","year":"2024","unstructured":"Liang, S. et al. Urinary equol and equol-predicting microbial species are favorably associated with cardiometabolic risk markers in Chinese adults. J. Am. Heart Assoc. 13, e034126 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"1074_CR49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MCG.0000000000001676","volume":"56","author":"M d\u2019Afflitto","year":"2022","unstructured":"d\u2019Afflitto, M. et al. Association between sex hormone levels and gut microbiota composition and diversity-a systematic review. J. Clin. Gastroenterol. 56, 384\u2013392 (2022).","journal-title":"J. Clin. Gastroenterol."},{"key":"1074_CR50","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084\u20131088 (2013).","journal-title":"Science"},{"key":"1074_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00281-018-0716-7","volume":"41","author":"R Vemuri","year":"2019","unstructured":"Vemuri, R. et al. The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility. Semin Immunopathol. 41, 265\u2013275 (2019).","journal-title":"Semin Immunopathol."},{"key":"1074_CR52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/NMC.0000000000000372","volume":"42","author":"SM Edwards","year":"2017","unstructured":"Edwards, S. M. et al. The Maternal Gut Microbiome During Pregnancy. MCN Am. J. Matern Child Nurs. 42, 310\u2013317 (2017).","journal-title":"MCN Am. J. Matern Child Nurs."},{"key":"1074_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00273-22","volume":"7","author":"BA Peters","year":"2022","unstructured":"Peters, B. A. et al. Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the hispanic community health study\/study of latinos. mSystems 7, e0027322 (2022).","journal-title":"mSystems"},{"key":"1074_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00816-5","volume":"11","author":"HH Rashwan","year":"2025","unstructured":"Rashwan, H. H. et al. Unravelling novel microbial players in the breast tissue of TNBC patients: a meta-analytic perspective. npj Biofilms Microbiomes 11, 182 (2025).","journal-title":"npj Biofilms Microbiomes"},{"key":"1074_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14942-5","volume":"11","author":"C Grazon","year":"2020","unstructured":"Grazon, C. et al. A progesterone biosensor derived from microbial screening. Nat. Commun. 11, 1276 (2020).","journal-title":"Nat. Commun."},{"key":"1074_CR56","doi-asserted-by":"publisher","first-page":"1238855","DOI":"10.3389\/fmicb.2023.1238855","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Common and unique testosterone and 17 beta-estradiol degradation mechanisms in Comamonas testosteroni JLU460ET by transcriptome analysis. Front Microbiol 14, 1238855 (2023).","journal-title":"Front Microbiol"},{"key":"1074_CR57","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1128\/JB.00345-15","volume":"197","author":"P Halang","year":"2015","unstructured":"Halang, P. et al. Response of vibrio cholerae to the catecholamine hormones epinephrine and norepinephrine. J. Bacteriol. 197, 3769\u20133778 (2015).","journal-title":"J. Bacteriol."},{"key":"1074_CR58","doi-asserted-by":"publisher","first-page":"1147585","DOI":"10.3389\/fcimb.2023.1147585","volume":"13","author":"ZK Hammouda","year":"2023","unstructured":"Hammouda, Z. K., Wasfi, R. & Abdeltawab, N. F. Hormonal drugs: influence on growth, biofilm formation, and adherence of selected gut microbiota. Front Cell Infect. Microbiol 13, 1147585 (2023).","journal-title":"Front Cell Infect. Microbiol"},{"key":"1074_CR59","doi-asserted-by":"crossref","unstructured":"Sisk-Hackworth, L. et al. Genetic hypogonadal (Gnrh1(hpg)) mouse model uncovers influence of reproductive axis on maturation of the gut microbiome during puberty. bioRxiv, (2024).","DOI":"10.1101\/2024.07.01.601610"},{"key":"1074_CR60","first-page":"11","volume":"11","author":"R Siddiqui","year":"2022","unstructured":"Siddiqui, R. et al. The Gut microbiome and female health. Biol. (Basel) 11, 11 (2022).","journal-title":"Biol. (Basel)"},{"key":"1074_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66865-2","volume":"10","author":"EK Mallott","year":"2020","unstructured":"Mallott, E. K. et al. Reproductive hormones mediate changes in the gut microbiome during pregnancy and lactation in Phayre\u2019s leaf monkeys. Sci. Rep. 10, 9961 (2020).","journal-title":"Sci. Rep."},{"key":"1074_CR62","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/diagnostics13061193","volume":"13","author":"MG Park","year":"2023","unstructured":"Park, M. G., Cho, S. & Oh, M. M. Menopausal Changes in the Microbiome\u2014A Review Focused on the Genitourinary Microbiome. Diagnostics 13, 1193 (2023).","journal-title":"Diagnostics"},{"key":"1074_CR63","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761\u20131772 (2007).","journal-title":"Diabetes"},{"key":"1074_CR64","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/1878-0261.12975","volume":"16","author":"T Wilkie","year":"2022","unstructured":"Wilkie, T. et al. Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4. Mol. Oncol. 16, 1508\u20131522 (2022).","journal-title":"Mol. Oncol."},{"key":"1074_CR65","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.immuni.2015.03.004","volume":"42","author":"S-U Seo","year":"2015","unstructured":"Seo, S.-U. et al. Distinct Commensals Induce Interleukin-1\u03b2 via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. Immunity 42, 744\u2013755 (2015).","journal-title":"Immunity"},{"key":"1074_CR66","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.7150\/ijbs.92988","volume":"20","author":"W-X Xu","year":"2024","unstructured":"Xu, W.-X. et al. The burgeoning significance of liquid-liquid phase separation in the pathogenesis and therapeutics of cancers. Int. J. Biol. Sci. 20, 1652 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"1074_CR67","doi-asserted-by":"publisher","first-page":"E7554","DOI":"10.1073\/pnas.1607235113","volume":"113","author":"J Yan","year":"2016","unstructured":"Yan, J. et al. Gut microbiota induce IGF-1 and promote bone formation and growth. Proc. Natl. Acad. Sci. 113, E7554\u2013E7563 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1074_CR68","doi-asserted-by":"publisher","first-page":"G278","DOI":"10.1152\/ajpgi.00092.2011","volume":"301","author":"X Huo","year":"2011","unstructured":"Huo, X. et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-\u03baB activation in benign Barrett\u2019s epithelial cells. Am. J. Physiol.-Gastrointest. Liver Physiol. 301, G278\u2013G286 (2011).","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"1074_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05709-3","volume":"22","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Influence of the gut microbiota on immune cell interactions and cancer treatment. J. Transl. Med. 22, 939 (2024).","journal-title":"J. Transl. Med."},{"key":"1074_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35329-z","volume":"8","author":"L Costantini","year":"2018","unstructured":"Costantini, L. et al. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions. Sci. Rep. 8, 16893 (2018).","journal-title":"Sci. Rep."},{"key":"1074_CR71","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/AEM.00242-14","volume":"80","author":"C Urbaniak","year":"2014","unstructured":"Urbaniak, C. et al. Microbiota of human breast tissue. Appl. Environ. Microbiol. 80, 3007\u20133014 (2014).","journal-title":"Appl. Environ. Microbiol."},{"key":"1074_CR72","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41416-023-02554-x","volume":"130","author":"JE Joo","year":"2024","unstructured":"Joo, J. E. et al. Intratumoral presence of the genotoxic gut bacteria pks+ E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer. Br. J. Cancer 130, 728\u2013740 (2024).","journal-title":"Br. J. Cancer"},{"key":"1074_CR73","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"JP Nougayr\u00e8de","year":"2006","unstructured":"Nougayr\u00e8de, J. P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848\u2013851 (2006).","journal-title":"Science"},{"key":"1074_CR74","doi-asserted-by":"publisher","first-page":"e22166","DOI":"10.1096\/fj.202101443RR","volume":"36","author":"S Kang","year":"2022","unstructured":"Kang, S. et al. Estrogen enhanced the expression of IL-17 by tissue-resident memory \u03b3\u03b4T cells from uterus via interferon regulatory factor 4. FASEB J. 36, e22166 (2022).","journal-title":"FASEB J."},{"key":"1074_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55720-8","volume":"9","author":"DM Walsh","year":"2019","unstructured":"Walsh, D. M. et al. Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome). Sci. Rep. 9, 19213 (2019).","journal-title":"Sci. Rep."},{"key":"1074_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0368-y","volume":"8","author":"MRS Walther-Ant\u00f3nio","year":"2016","unstructured":"Walther-Ant\u00f3nio, M. R. S. et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 8, 122 (2016).","journal-title":"Genome Med."},{"key":"1074_CR77","doi-asserted-by":"crossref","unstructured":"Mohamed, A. A., Al-Ramadi, B. K. & Fernandez-Cabezudo, M. J. Interplay between microbiota and \u03b3\u03b4 t cells: insights into immune homeostasis and neuro-immune interactions. Int. J. Mol. Sci. 25, 1747 (2024).","DOI":"10.3390\/ijms25031747"},{"key":"1074_CR78","doi-asserted-by":"publisher","first-page":"11537","DOI":"10.1073\/pnas.1001261107","volume":"107","author":"G Cuevas-Ramos","year":"2010","unstructured":"Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. 107, 11537\u201311542 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1074_CR79","doi-asserted-by":"publisher","first-page":"uqad032","DOI":"10.1093\/femsml\/uqad032","volume":"4","author":"RA Stein","year":"2023","unstructured":"Stein, R. A. & Riber, L. Epigenetic effects of short-chain fatty acids from the large intestine on host cells. Microlife 4, uqad032 (2023).","journal-title":"Microlife"},{"key":"1074_CR80","doi-asserted-by":"publisher","first-page":"2485s","DOI":"10.1093\/jn\/133.7.2485S","volume":"133","author":"JR Davie","year":"2003","unstructured":"Davie, J. R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485s\u20132493s (2003).","journal-title":"J. Nutr."},{"key":"1074_CR81","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.3390\/ijms25137175","volume":"25","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. The gut microbial regulation of epigenetic modification from a metabolic perspective. Int. J. Mol. Sci. 25, 7175 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1074_CR82","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1007\/s00394-020-02282-5","volume":"59","author":"E Birkeland","year":"2020","unstructured":"Birkeland, E. et al. Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial. Eur. J. Nutr. 59, 3325\u20133338 (2020).","journal-title":"Eur. J. Nutr."},{"key":"1074_CR83","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623\u2013632 (2019).","journal-title":"Nat. Microbiol."},{"key":"1074_CR84","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2016.44","volume":"21","author":"P Zheng","year":"2016","unstructured":"Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host\u2019s metabolism. Mol. Psychiatry 21, 786\u2013796 (2016).","journal-title":"Mol. Psychiatry"},{"key":"1074_CR85","doi-asserted-by":"publisher","first-page":"e01679-24","DOI":"10.1128\/mbio.01679-24","volume":"16","author":"Y Alam","year":"2025","unstructured":"Alam, Y. et al. Variation in human gut microbiota impacts tamoxifen pharmacokinetics. mBio 16, e01679-24 (2025).","journal-title":"mBio"},{"key":"1074_CR86","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1021\/acs.jcim.1c01414","volume":"62","author":"AP Challa","year":"2022","unstructured":"Challa, A. P. et al. Virtual screening for the discovery of microbiome \u03b2-Glucuronidase inhibitors to alleviate cancer drug toxicity. J. Chem. Inf. Modeling 62, 1783\u20131793 (2022).","journal-title":"J. Chem. Inf. Modeling"},{"key":"1074_CR87","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00432-024-06028-2","volume":"150","author":"LE Hillege","year":"2024","unstructured":"Hillege, L. E. et al. The role of gut microbial \u03b2-glucuronidases in carcinogenesis and cancer treatment: a scoping review. J. Cancer Res Clin. Oncol. 150, 495 (2024).","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"1074_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91734-1","volume":"15","author":"LE Hillege","year":"2025","unstructured":"Hillege, L. E. et al. The gut microbiota during tamoxifen therapy in patients with breast cancer. Sci. Rep. 15, 7874 (2025).","journal-title":"Sci. Rep."},{"key":"1074_CR89","doi-asserted-by":"publisher","first-page":"P1-02-05","DOI":"10.1158\/1538-7445.SABCS22-P1-02-05","volume":"83","author":"A Arnone","year":"2023","unstructured":"Arnone, A. et al. Abstract P1-02-05: endocrine-targeted therapies modify the gut microbiome affecting responsiveness in ER+ breast cancer. Cancer Res. 83, P1-02-05\u2013P1-02-05 (2023).","journal-title":"Cancer Res."},{"key":"1074_CR90","doi-asserted-by":"publisher","first-page":"e0146509","DOI":"10.1371\/journal.pone.0146509","volume":"11","author":"ST Kelley","year":"2016","unstructured":"Kelley, S. T. et al. The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome. PLoS One 11, e0146509 (2016).","journal-title":"PLoS One"},{"key":"1074_CR91","doi-asserted-by":"publisher","first-page":"e00879-25","DOI":"10.1128\/msystems.00879-25","volume":"10","author":"Taha Sheikh","year":"2025","unstructured":"Sheikh, T. aha et al. Integrated insights into gut microbiota and metabolomic landscape in breast cancer patients undergoing adjuvant endocrine therapy. mSystems 10, e00879-25 (2025).","journal-title":"mSystems"},{"key":"1074_CR92","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41418-021-00784-1","volume":"28","author":"S Terrisse","year":"2021","unstructured":"Terrisse, S. et al. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ. 28, 2778\u20132796 (2021).","journal-title":"Cell Death Differ."},{"key":"1074_CR93","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/gidisord6040056","volume":"6","author":"J Basnet","year":"2024","unstructured":"Basnet, J. et al. Impact of probiotics and prebiotics on gut microbiome and hormonal regulation. Gastrointest. Disord. 6, 801\u2013815 (2024).","journal-title":"Gastrointest. Disord."},{"key":"1074_CR94","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MCG.0000000000002002","volume":"58","author":"F Guarner","year":"2024","unstructured":"Guarner, F. et al. World gastroenterology organisation global guidelines: probiotics and prebiotics. J. Clin. Gastroenterol. 58, 533\u2013553 (2024).","journal-title":"J. Clin. Gastroenterol."},{"key":"1074_CR95","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen, S. et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. 18, 649\u2013667 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1074_CR96","doi-asserted-by":"publisher","first-page":"e70118","DOI":"10.1002\/ddr.70118","volume":"86","author":"AA Allam","year":"2025","unstructured":"Allam, A. A. et al. \u03b2-glucuronidase inhibition in drug development: emerging strategies for mitigating drug-induced toxicity and enhancing therapeutic outcomes. Drug Dev. Res. 86, e70118 (2025).","journal-title":"Drug Dev. Res."},{"key":"1074_CR97","doi-asserted-by":"publisher","first-page":"105784","DOI":"10.1016\/j.jff.2023.105784","volume":"109","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. The dietary intervention of synbiotic preparation promotes the bioconversion of soy isoflavones to equol and its metabolic mechanism. J. Funct. Foods 109, 105784 (2023).","journal-title":"J. Funct. Foods"},{"key":"1074_CR98","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/antiox13030259","volume":"13","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Deciphering the crucial roles of the quorum-sensing transcription factor SdiA in NADPH metabolism and (S)-equol production in Escherichia coli Nissle 1917. Antioxidants 13, 259 (2024).","journal-title":"Antioxidants"},{"key":"1074_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.heliyon.2020.e05298","volume":"6","author":"SE Mustafa","year":"2020","unstructured":"Mustafa, S. E. et al. Impact of prebiotics on equol production from soymilk isoflavones by two Bifidobacterium species. Heliyon 6, 10 (2020).","journal-title":"Heliyon"},{"key":"1074_CR100","doi-asserted-by":"publisher","first-page":"9621668","DOI":"10.1155\/2022\/9621668","volume":"2022","author":"J Mishra","year":"2022","unstructured":"Mishra, J. et al. Inflammatory bowel disease therapeutics: a focus on probiotic engineering. Mediators Inflamm. 2022, 9621668 (2022).","journal-title":"Mediators Inflamm."},{"key":"1074_CR101","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ajcn\/79.2.282","volume":"79","author":"L Keinan-Boker","year":"2004","unstructured":"Keinan-Boker, L. et al. Dietary phytoestrogens and breast cancer risk123. Am. J. Clin. Nutr. 79, 282\u2013288 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"1074_CR102","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.clnu.2018.04.010","volume":"38","author":"A Kazemi","year":"2019","unstructured":"Kazemi, A. et al. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin. Nutr. 38, 522\u2013528 (2019).","journal-title":"Clin. Nutr."},{"key":"1074_CR103","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2021.11.023","volume":"100","author":"P Tian","year":"2022","unstructured":"Tian, P. et al. Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: a randomized clinical trial. Brain Behav. Immun. 100, 233\u2013241 (2022).","journal-title":"Brain Behav. Immun."},{"key":"1074_CR104","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fmicb.2018.01182","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H. et al. To construct an engineered (S)-equol resistant E. coli for in vitro (S)-equol production. Front. Microbiol. 9, 1182 (2018).","journal-title":"Front. Microbiol."},{"key":"1074_CR105","doi-asserted-by":"publisher","first-page":"109328","DOI":"10.1016\/j.ijfoodmicro.2021.109328","volume":"360","author":"A Ruiz de la Bastida","year":"2021","unstructured":"Ruiz de la Bastida, A. et al. Heterologous production of equol by lactic acid bacteria strains in culture medium and food. Int. J. Food Microbiol. 360, 109328 (2021).","journal-title":"Int. J. Food Microbiol."},{"key":"1074_CR106","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1200\/JCO-25-00374","volume":"43","author":"R Barragan-Carrillo","year":"2025","unstructured":"Barragan-Carrillo, R., Zengin, Z. B. & Pal, S. K. Microbiome Modulation for the Treatment of Solid Neoplasms. J. Clin. Oncol. 43, 2734\u20132738 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1074_CR107","doi-asserted-by":"publisher","first-page":"G711","DOI":"10.1152\/ajpgi.00171.2024","volume":"327","author":"MS Bohm","year":"2024","unstructured":"Bohm, M. S. et al. Fecal microbial transplants as investigative tools in cancer. Am. J. Physiol.-Gastrointest. Liver Physiol. 327, G711\u2013G726 (2024).","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"1074_CR108","unstructured":"administration, F..a.d., FDA safety alert on serious adverse events and pathogen transmission in FMT. Food and Drug Administration (2020)."},{"key":"1074_CR109","unstructured":"administration, F..a.d., FDA additional safety protections requiring EPEC\/STEC donor testing and quarantine. Food and Drug Administration (2020)."},{"key":"1074_CR110","doi-asserted-by":"publisher","first-page":"103025","DOI":"10.1016\/j.ctrv.2025.103025","volume":"140","author":"D Wekking","year":"2025","unstructured":"Wekking, D. et al. Fecal microbiota transplantation to enhance cancer treatment outcomes across different cancer types: A systematic literature review. Cancer Treat. Rev. 140, 103025 (2025).","journal-title":"Cancer Treat. Rev."},{"key":"1074_CR111","doi-asserted-by":"publisher","first-page":"20220954","DOI":"10.1515\/biol-2022-0954","volume":"20","author":"Y Wu","year":"2025","unstructured":"Wu, Y. et al. Research progress on fecal microbiota transplantation in tumor prevention and treatment. Open Life Sci. 20, 20220954 (2025).","journal-title":"Open Life Sci."},{"key":"1074_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00678-x","volume":"11","author":"J Sun","year":"2025","unstructured":"Sun, J. et al. Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation. npj Biofilms Microbiomes 11, 43 (2025).","journal-title":"npj Biofilms Microbiomes"},{"key":"1074_CR113","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/gidisord7010007","volume":"7","author":"MO Yaqub","year":"2025","unstructured":"Yaqub, M. O. et al. Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine. Gastrointest. Disord. 7, 7 (2025).","journal-title":"Gastrointest. Disord."},{"key":"1074_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10621-7","volume":"25","author":"D Bars-Cortina","year":"2024","unstructured":"Bars-Cortina, D. et al. Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota. BMC Genomics 25, 730 (2024).","journal-title":"BMC Genomics"},{"key":"1074_CR115","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12905-025-03843-8","volume":"25","author":"C Bose","year":"2025","unstructured":"Bose, C. et al. Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation. BMC Women\u2019s. Health 25, 416 (2025).","journal-title":"BMC Women\u2019s. Health"},{"key":"1074_CR116","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","volume":"28","author":"KA Lee","year":"2022","unstructured":"Lee, K. A. et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat. Med 28, 535\u2013544 (2022).","journal-title":"Nat. Med"},{"key":"1074_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/mrr.2023.33","volume":"3","author":"Y Ou","year":"2024","unstructured":"Ou, Y. et al. Methodological recommendations for human microbiota-gut-brain axis research. Microbiome Res Rep. 3, 1 (2024).","journal-title":"Microbiome Res Rep."},{"key":"1074_CR118","doi-asserted-by":"publisher","first-page":"1691503","DOI":"10.3389\/fmicb.2025.1691503","volume":"16","author":"I Khelfaoui","year":"2025","unstructured":"Khelfaoui, I. et al. Beyond just correlation: causal machine learning for the microbiome, from prediction to health policy with econometric tools. Front Microbiol 16, 1691503 (2025).","journal-title":"Front Microbiol"},{"key":"1074_CR119","doi-asserted-by":"publisher","first-page":"e100086","DOI":"10.1136\/egastro-2024-100086","volume":"2","author":"C Prosty","year":"2024","unstructured":"Prosty, C. et al. Causal role of the gut microbiome in certain human diseases: a narrative review. eGastroenterology 2, e100086 (2024).","journal-title":"eGastroenterology"},{"key":"1074_CR120","doi-asserted-by":"publisher","first-page":"112534","DOI":"10.1016\/j.mce.2025.112534","volume":"603","author":"VW Li","year":"2025","unstructured":"Li, V. W. et al. Mass spectrometric profiling of primary estrogens and estrogen metabolites in human stool and plasma partially elucidates the role of the gut microbiome in estrogen recycling. Mol. Cell. Endocrinol. 603, 112534 (2025).","journal-title":"Mol. Cell. Endocrinol."},{"key":"1074_CR121","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ijc.35427","volume":"157","author":"AH Larnder","year":"2025","unstructured":"Larnder, A. H., Manges, A. R. & Murphy, R. A. The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer. Int J. Cancer 157, 599\u2013613 (2025).","journal-title":"Int J. Cancer"},{"key":"1074_CR122","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.biologicals.2024.101758","volume":"86","author":"I Belotserkovsky","year":"2024","unstructured":"Belotserkovsky, I. et al. Standards for fecal microbiota transplant: Tools and therapeutic advances. Biologicals 86, 101758 (2024).","journal-title":"Biologicals"},{"key":"1074_CR123","doi-asserted-by":"crossref","unstructured":"Justice, M. J. Sex matters in preclinical research. Dis. Model Mech. 17, dmm050759 (2024).","DOI":"10.1242\/dmm.050759"},{"key":"1074_CR124","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-025-09854-7","volume":"650","author":"F Asnicar","year":"2026","unstructured":"Asnicar, F. et al. Gut micro-organisms associated with health, nutrition and dietary interventions. Nature 650, 450\u2013458 (2026).","journal-title":"Nature"},{"key":"1074_CR125","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41575-025-01041-3","volume":"22","author":"A Metwaly","year":"2025","unstructured":"Metwaly, A. et al. A Consensus statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research. Nat. Rev. Gastroenterol. Hepatol. 22, 343\u2013356 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1074_CR126","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi, C. et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat. Med. 27, 1885\u20131892 (2021).","journal-title":"Nat. Med."},{"key":"1074_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00883-8","volume":"12","author":"J Bautista","year":"2026","unstructured":"Bautista, J. et al. Gut microbiome\u2013driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming. npj Biofilms Microbiomes 12, 21 (2026).","journal-title":"npj Biofilms Microbiomes"},{"key":"1074_CR128","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3389\/fmed.2026.1827694","volume":"13","author":"J Bautista","year":"2026","unstructured":"Bautista, J. et al. Host\u2013microbiome interactions in breast cancer progression and treatment response. Front. Med. 13, 2026 (2026).","journal-title":"Front. Med."},{"key":"1074_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00810-2","volume":"11","author":"C-H Tsai","year":"2025","unstructured":"Tsai, C.-H. et al. Longitudinal changes in gut microbiota composition during endocrine therapy in hormone receptor-positive breast cancer patients. npj Breast Cancer 11, 107 (2025).","journal-title":"npj Breast Cancer"},{"key":"1074_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01781-5","volume":"12","author":"Y Han","year":"2024","unstructured":"Han, Y. et al. Longitudinal multi-omics analysis uncovers the altered landscape of gut microbiota and plasma metabolome in response to high altitude. Microbiome 12, 70 (2024).","journal-title":"Microbiome"},{"key":"1074_CR131","doi-asserted-by":"crossref","unstructured":"He, B., et al., Microbiome-transcriptome-histology triad enhances survival risk stratification in multiple cancers. Computational Biology and Chemistry, 2025: p. 108703.","DOI":"10.1016\/j.compbiolchem.2025.108703"},{"key":"1074_CR132","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fonc.2025.1666830","volume":"15","author":"B Oh","year":"2025","unstructured":"Oh, B. et al. The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differences. Front. Oncol. 15, 2025 (2025).","journal-title":"Front. Oncol."},{"key":"1074_CR133","first-page":"100018","volume":"3","author":"U Shahid","year":"2025","unstructured":"Shahid, U. Microbiome-guided precision medicine: Mechanistic insights, multi-omics integration, and translational horizons. J. Precis. Med.: Health Dis. 3, 100018 (2025).","journal-title":"J. Precis. Med.: Health Dis."},{"key":"1074_CR134","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fmicb.2024.1449090","volume":"15","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis. Front. Microbiol. 15, 2024 (2024).","journal-title":"Front. Microbiol."},{"key":"1074_CR135","doi-asserted-by":"publisher","first-page":"2328868","DOI":"10.1080\/19490976.2024.2328868","volume":"16","author":"L Li","year":"2024","unstructured":"Li, L., Huang, X. & Chen, H. Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics. Gut Microbes 16, 2328868 (2024).","journal-title":"Gut Microbes"},{"key":"1074_CR136","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/jpm14090908","volume":"14","author":"A Cattaneo","year":"2024","unstructured":"Cattaneo, A. et al. Recommendations for the Application of Sex and Gender Medicine in Preclinical, Epidemiological and Clinical Research. J. Personalized Med. 14, 908 (2024).","journal-title":"J. Personalized Med."},{"key":"1074_CR137","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.xcrm.2024.101738","volume":"5","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease. Cell Rep. Med. 5, 101738 (2024).","journal-title":"Cell Rep. Med."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01074-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:02:49Z","timestamp":1791907369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01074-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-01074-9","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors used generative-AI\/language-assistance tools (InstaText, Wordvice, and DeepL) only for structural editing and language polishing. These tools were not used to generate scientific content, interpret results, or create citations. All factual claims, data statements, and references cited in this manuscript were checked and verified manually by the authors against the original source papers prior to submission; no citations were fabricated or created by AI. The authors accept full responsibility for the accuracy and integrity of the content.","order":2,"name":"Ethics","label":"Generative AI Statement","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"203"}}